Study of Vedolizumab Following Multiple Intravenous Doses in Patients With Ulcerative Colitis
Status:
Completed
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
The main objectives of this study were to evaluate the safety, tolerability, pharmacokinetics
(PK), and pharmacodynamics (PD) of multiple doses of vedolizumab in patients with ulcerative
colitis (UC).